Figure 5. Molecular docking analysis for ADRB1, ACE, and HMGCR with aconitine, liquiritin and 6-gingerol.
(A) Homology model and the binding pocket for human ADRB1. Detailed interaction mode between (B) aconitine/(C) liquiritin/(D) 6-gingerol and ADRB1. Docking analysis of HMGCR with (E) mevastatin, (F) aconitine, (G) liquiritin and (H) 6-gingerol. Docking analysis of ACE with (I) lisinopril, (J) aconitine, (K) liquiritin and (L) 6-gingerol.